ionis ghr-lrx
Nucleic acidexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 11, 2018 (NCT03548415)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Growth hormone receptorINHIBITOR
GHR inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04522180 | Phase 2 | Dec 31, 2020 | Ionis Pharmaceuticals, Inc. |
| NCT03967249 | Phase 2 | Jun 30, 2019 | Ionis Pharmaceuticals, Inc. |
| NCT03548415 | Phase 2 | May 11, 2018 | Ionis Pharmaceuticals, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ionis Pharmaceuticals, Inc. | For profit | 3 | 3 | 1 | 2018 |
1 organizations
Page 1 / 1